PFM Health Sciences’s Becton Dickinson BDX Stock Holding History

PFM Health Sciences’s Portfolio BDX Stock Details BDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-91,571	Closed	-$21M	–	60
2025 Q1	$21M	Buy	+91,571	New	+$21.2M	1.52%	23
2024 Q4	–	Sell	-101,680	Closed	-$24.5M	–	87
2024 Q3	$24.5M	Sell	101,680 -29,698	-23%	-$6.96M	1.39%	25
2024 Q2	$30.7M	Sell	131,378 -40,174	-23%	-$9.46M	1.52%	24
2024 Q1	$42.5M	Sell	171,552 -28,489	-14%	-$6.82M	2%	13
2023 Q4	$48.8M	Buy	200,041 +46,086	+30%	+$11.4M	2.93%	8
2023 Q3	$39.8M	Hold	153,955	–	–	1.88%	23
2023 Q2	$40.6M	Buy	153,955 +2,942	+2%	+$747K	1.58%	31
2023 Q1	$37.4M	Buy	+151,013	New	+$36.9M	1.65%	28
2022 Q3	–	Sell	-130,697	Closed	-$32.2M	–	89
2022 Q2	$32.2M	Sell	130,697 -30,836	-19%	-$7.83M	1.23%	38
2022 Q1	$41.9M	Buy	+161,533	New	+$41.6M	1.57%	26
2020 Q2	–	Sell	-154,929	Closed	-$34.7M	–	79
2020 Q1	$34.7M	Buy	+154,929	New	+$38.3M	2.85%	11
2016 Q3	–	Sell	-239,012	Closed	-$39.5M	–	88
2016 Q2	$39.5M	Buy	239,012 +89,167	+60%	+$14.3M	1.19%	40
2016 Q1	$22.2M	Buy	+149,845	New	+$21.3M	0.68%	46

Other funds holding BDX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PFM Health Sciences's BDX Position: Q2 2025 in Review

PFM Health Sciences sold out of Becton Dickinson (BDX) in Q2 2025, closing a stake of 91,571 shares — an estimated $21M sold.

PFM Health Sciences first reported a position in BDX in Q1 2016 and held it in 13 quarters. The position peaked at $48.8M in Q4 2023. 1,516 funds tracked by Wall St. Rank hold BDX as of Q2 2025.

PFM Health Sciences reported no remaining Becton Dickinson position as of Q2 2025 after selling out during the quarter.
PFM Health Sciences sold 91,571 Becton Dickinson shares in Q2 2025, an estimated $21M.
PFM Health Sciences first reported a position in Becton Dickinson in Q1 2016 and held it in 13 quarters.
PFM Health Sciences's Becton Dickinson position peaked at $48.8M in Q4 2023.
1,516 funds tracked by Wall St. Rank held Becton Dickinson as of Q2 2025.

Based on PFM Health Sciences's 13F filing for Q2 2025, filed 14 Aug 2025.